Last Price
1.55
Today's Change
-0.07 (4.32%)
Day's Change
1.54 - 1.69
Trading Volume
169,673
Overview
Market Cap
53 Million
Shares Outstanding
34 Million
Avg Volume
171,033
Avg Price (50 Days)
2.13
Avg Price (200 Days)
4.45
PE Ratio
-2.82
EPS
-0.55
Earnings Announcement
26-Feb-2025
Previous Close
1.62
Open
1.69
Day's Range
1.545 - 1.69
Year Range
1.078 - 17.75
Trading Volume
169,835
Price Change Highlight
1 Day Change
-4.32%
5 Day Change
-10.92%
1 Month Change
-26.89%
3 Month Change
-49.01%
6 Month Change
-68.17%
Ytd Change
-22.11%
1 Year Change
-89.24%
3 Year Change
-94.67%
5 Year Change
-94.67%
10 Year Change
-94.67%
Max Change
-94.67%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
FibroBiologics, Inc., a clinical-stage cell therapy company, develops and commercializes fibroblast-based therapies in the United States. It is developing CybroCell, for the treatment of degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for wound healing. The company is also on the early-stage research of CYTER915, which is designed to regenerate or reinvigorate production of the thymus and/or spleen; CYPS317, for the treatment of psoriasis; and TCB190 to treat certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
1
https://e.vg/SCEPDhSaA
2
https://e.vg/SCEPDhSaA
3
https://e.vg/lZbMkkPTL
4
https://e.vg/TNtALgyhS
5
https://e.vg/WuiqJqAao
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
